Tokyo Tape
Sign in
← CellSeed

Quarterly report · Q1

7776.TEDINET S100TFKG
Period2024-01-01 → 2024-03-31
Filed2024-05-15
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 32
MetricValuePeriodScopeSource row
Revenue¥34m2024-01-01 → 2024-03-31StandaloneNet sales
Revenue¥190m2023-01-01 → 2023-12-31StandaloneNet sales (5-year summary)
Revenue¥31m2023-01-01 → 2023-03-31StandaloneNet sales
Operating income−¥233m2024-01-01 → 2024-03-31StandaloneOperating income
Operating income−¥182m2023-01-01 → 2023-03-31StandaloneOperating income
Ordinary income−¥231m2024-01-01 → 2024-03-31StandaloneOrdinary income
Ordinary income−¥710m2023-01-01 → 2023-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥184m2023-01-01 → 2023-03-31StandaloneOrdinary income
Profit before tax−¥229m2024-01-01 → 2024-03-31StandaloneIncome before income taxes
Profit before tax−¥184m2023-01-01 → 2023-03-31StandaloneIncome before income taxes
Net income−¥230m2024-01-01 → 2024-03-31StandaloneProfit loss
Net income−¥847m2023-01-01 → 2023-12-31StandaloneNet income loss (5-year summary)
Net income−¥184m2023-01-01 → 2023-03-31StandaloneProfit loss
Total assets¥2.4bnat 2024-03-31StandaloneAssets
Total assets¥2.5bnat 2023-12-31StandaloneAssets
Total assets¥2.0bnat 2023-03-31StandaloneTotal assets (5-year summary)
Total liabilities¥291mat 2024-03-31StandaloneLiabilities
Total liabilities¥301mat 2023-12-31StandaloneLiabilities
Net assets / equity¥2.1bnat 2024-03-31StandaloneNet assets
Net assets / equity¥2.2bnat 2023-12-31StandaloneNet assets
Net assets / equity¥1.6bnat 2023-03-31StandaloneNet assets (5-year summary)
Cash and deposits¥2.1bnat 2024-03-31StandaloneCash and deposits
Cash and deposits¥2.2bnat 2023-12-31StandaloneCash and deposits
EPS (basic)¥-7.242024-01-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-29.432023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.812023-01-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
Equity ratio86.9%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio86.9%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio79.2%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Shares issued32,172,719at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued31,459,019at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued27,659,419at 2023-03-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31−¥55m
jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue2024-01-01 → 2024-03-31¥387,000
jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue external2024-01-01 → 2024-03-31¥387,000
jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segmentsegment profit2024-01-01 → 2024-03-31−¥164m
jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue2024-01-01 → 2024-03-31¥34m
jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue external2024-01-01 → 2024-03-31¥34m
jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segmentsegment profit2024-01-01 → 2024-03-31−¥13m
—segment totalrevenue2024-01-01 → 2024-03-31¥34m
—segment totalrevenue external2024-01-01 → 2024-03-31¥34m
—segment totalsegment profit2024-01-01 → 2024-03-31−¥177m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31−¥54m
jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue2023-01-01 → 2023-03-31¥249,000
jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue external2023-01-01 → 2023-03-31¥249,000
jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segmentsegment profit2023-01-01 → 2023-03-31−¥115m
jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue2023-01-01 → 2023-03-31¥30m
jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue external2023-01-01 → 2023-03-31¥30m
jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segmentsegment profit2023-01-01 → 2023-03-31−¥13m
—segment totalrevenue2023-01-01 → 2023-03-31¥31m
—segment totalrevenue external2023-01-01 → 2023-03-31¥31m
—segment totalsegment profit2023-01-01 → 2023-03-31−¥128m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 298
ItemContextValueUnit
LiabilitiesCurrentQuarterInstant_NonConsolidatedMember290653000JPY
Capital stockPrior1YearInstant_NonConsolidatedMember2384311000JPY
Capital stockCurrentQuarterInstant_NonConsolidatedMember2459243000JPY
Capital surplusPrior1YearInstant_NonConsolidatedMember1363892000JPY
Capital surplusCurrentQuarterInstant_NonConsolidatedMember1438824000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember-1606214000JPY
Retained earningsCurrentQuarterInstant_NonConsolidatedMember-1835879000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-227000JPY
Treasury stockCurrentQuarterInstant_NonConsolidatedMember-227000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember2141761000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember2061960000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember－JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant_NonConsolidatedMember543000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember－JPY
Valuation and translation adjustmentsCurrentQuarterInstant_NonConsolidatedMember543000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember22959000JPY
Subscription rights to sharesCurrentQuarterInstant_NonConsolidatedMember20696000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember2164721000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember2083201000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember2465768000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember2373855000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember30696000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember34238000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember15200000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember16312000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember15496000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember17925000JPY
Research and development expenses sgaPrior1YTDDuration_NonConsolidatedMember111301000JPY
Research and development expenses sgaCurrentYTDDuration_NonConsolidatedMember156388000JPY
Other sgaPrior1YTDDuration_NonConsolidatedMember85894000JPY
Other sgaCurrentYTDDuration_NonConsolidatedMember94129000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember197196000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember250518000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-181700000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-232593000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember5000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember10000JPY
Foreign exchange gains noiPrior1YTDDuration_NonConsolidatedMember－JPY
Foreign exchange gains noiCurrentYTDDuration_NonConsolidatedMember2118000JPY
Commission fee noiPrior1YTDDuration_NonConsolidatedMember13000JPY
Commission fee noiCurrentYTDDuration_NonConsolidatedMember18000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember2000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember2000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember21000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember2149000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember196000JPY
Interest expenses noeCurrentYTDDuration_NonConsolidatedMember515000JPY
Stock issuance cost prior noePrior1YTDDuration_NonConsolidatedMember2274000JPY
Stock issuance cost prior noeCurrentYTDDuration_NonConsolidatedMember524000JPY
Foreign exchange losses noePrior1YTDDuration_NonConsolidatedMember215000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2023-12-31pass
balance sheet identitynon_consolidated 2024-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-03-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass